Inborn errors of metabolism
Showing 26 - 50 of 6,907
Urea Cycle Disorder, Inborn Errors of Metabolism Trial in Philadelphia (UCD Anamix Infant)
Completed
- Urea Cycle Disorder
- Inborn Errors of Metabolism
- UCD Anamix Infant
-
Philadelphia, PennsylvaniaChildren's hospital of Philadelphia
Dec 8, 2021
Methylmalonic Acidemia (MMA) Trial run by the Selecta Biosciences, Inc. (SEL-302)
Recruiting
- Methylmalonic Acidemia (MMA)
-
Bethesda, MarylandNational Human Genome Research Institute, National Institutes of
Mar 9, 2023
Cardiac Manifestation and Inherited Metabolic Diseases
Recruiting
- Metabolism, Inborn Errors
-
Lausanne, Vaud, SwitzerlandLausanne University Hospital
Aug 7, 2021
Leukemia, Inborn Errors of Metabolism, Bone Marrow Failure Syndromes Trial in Philadelphia (Transplant of stem cells with
Recruiting
- Leukemia
- +4 more
- Transplant of stem cells with CD3+/CD19+ depletion (CliniMACs)
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 2, 2021
Methylmalonic Acidemia, Propionic Acidemia Trial in San Francisco, Remote (Registry)
Recruiting
- Methylmalonic Acidemia
- Propionic Acidemia
- Registry
-
San Francisco, California
- +2 more
Jun 27, 2022
Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell
Completed
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Fludarabine Drug Exposure in Pediatric Bone Marrow
Completed
- Hematologic Malignancies
- +7 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Clofarabine and Fludarabine Drug Exposure in Pediatric Bone
Completed
- Hematologic Malignancies
- +7 more
- Clofarabine
- Fludarabine Injection
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 27, 2021
Methylmalonic Acidemia Trial in United States (hLB-001)
Recruiting
- Methylmalonic Acidemia
- hLB-001
-
Atlanta, Georgia
- +3 more
Aug 16, 2022
Hematologic Malignancies, Inborn Errors of Metabolism Disorders, Immune Deficiencies Trial in Durham (CliniMACS CD34 Reagent
Available
- Hematologic Malignancies
- +2 more
- CliniMACS CD34 Reagent System
-
Durham, North CarolinaDuke University Medical Center
Nov 12, 2021
Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency Trial in Buffalo, Oklahoma City (Sucraid
Recruiting
- Congenital Sucrase-Isomaltase Deficiency
- +2 more
- Sucraid (sacrosidase) Oral Solution 8500 IU/mL
-
Buffalo, New York
- +1 more
Aug 16, 2022
Pyruvate Kinase Deficiency, Pyruvate Kinase Deficiency Anemia, Anemia Trial in Worldwide
Recruiting
- Pyruvate Kinase Deficiency
- +3 more
-
Boston, Massachusetts
- +4 more
Aug 5, 2022
Carbaglu® for Treatment of MMA and PA in Adults and Pediatrics
Recruiting
- Hyperammonemia
- +2 more
- Carglumic Acid
-
Washington, District of Columbia
- +1 more
Jun 30, 2022
Irritable Bowel Syndrome, Sucrose Intolerance Due to Sucrase-Isomaltase Deficiency, Carbohydrate; Malabsorption Trial
Not yet recruiting
- Irritable Bowel Syndrome
- +4 more
- Low-FODMAP diet
- Starch- and Sucrose Reduced Diet (SSRD)
- (no location specified)
Jan 18, 2022
Measurements in Inborn Errors of Metabolism
Completed
- Inborn Errors of Metabolism
- +7 more
- Survey
-
Zurich, SwitzerlandUniversity Children's Hospital Zurich
Nov 3, 2020
Non Infectious Presentation of Inborn Errors Of Immunity
Not yet recruiting
- Inborn Errors of Immunity
-
Sohag, EgyptSohag University Hospital
May 21, 2023
Exposure to Pollution, Glucocorticoid Resistance Trial in Vancouver (Placebo, Budesonide, Filtered Air)
Recruiting
- Exposure to Pollution
- Glucocorticoid Resistance
- Placebo
- +3 more
-
Vancouver, British Columbia, CanadaUniversity of British Columbia
Oct 29, 2021
Molybdenum Cofactor Deficiency, Type A Trial in Worldwide (ORGN001 (formerly ALXN1101))
Completed
- Molybdenum Cofactor Deficiency, Type A
- ORGN001 (formerly ALXN1101)
-
Milwaukee, Wisconsin
- +5 more
Oct 13, 2022
Prospective Research Rare Kidney Stones (ProRKS)
Recruiting
- Hyperoxaluria
- +4 more
-
Birmingham, Alabama
- +10 more
Nov 10, 2022
Pediatric Pyruvate Kinase Deficiency, Pediatric Hemolytic Anemia Trial in Barcelona, Madrid (Mitapivat, Mitapivat-matching )
Recruiting
- Pediatric Pyruvate Kinase Deficiency
- Pediatric Hemolytic Anemia
- Mitapivat
- Mitapivat-matching placebo
-
Barcelona, Spain
- +1 more
Aug 8, 2022
GLUT1 Deficiency Syndrome, Glucose Transporter Type 1 Deficiency Syndrome, Glucose Transporter type1 (GLUT-1) Deficiency Trial
Recruiting
- GLUT1 Deficiency Syndrome
- +3 more
- No intervention
-
Dallas, TexasUT Southwestern Medical Center
Feb 1, 2022
Biomarker for Hurler Disease (BioHurler)
Active, not recruiting
- Mucopolysaccharidosis Type I
- +2 more
-
Cairo, Egypt
- +4 more
May 12, 2021
Biomarker for Glycogen Storage Diseases (BioGlycogen)
Active, not recruiting
- Fructose Metabolism, Inborn Errors
- +9 more
-
Rostock, Germany
- +3 more
May 12, 2021
Pearson Syndrome Natural History Study
Recruiting
- Pearson Syndrome
- Single Large Scale Mitochondrial DNA Deletion Syndromes (SLSMDS)
-
Cleveland, Ohio
- +1 more
Aug 30, 2021